Cargando…
COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
The novel SARS-CoV-2 coronavirus (COVID-19) has become a global health crisis since its initial outbreak in Wuhan, China in December 2019. On January 30, 2020, the WHO recognized the COVID-19 outbreak as a Public Health Emergency, and on March 11, 2020, it was declared a pandemic. Although all age g...
Autores principales: | Mason, Kelly, Hasan, Sana, Darukhanavala, Amy, Kutney, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545686/ https://www.ncbi.nlm.nih.gov/pubmed/34722160 http://dx.doi.org/10.1016/j.jcte.2021.100268 |
Ejemplares similares
-
Eating disorders and body image in cystic fibrosis
por: Darukhanavala, Amy, et al.
Publicado: (2021) -
A Clinician’s guide to vitamin D supplementation for patients with cystic fibrosis
por: Wood, Colleen, et al.
Publicado: (2021) -
Obesity in cystic fibrosis
por: Kutney, Katherine A., et al.
Publicado: (2021) -
Treatment of cystic fibrosis related bone disease
por: Ullal, Jagdeesh, et al.
Publicado: (2021) -
Cystic fibrosis related liver disease and endocrine considerations
por: Sherwood, Jordan S., et al.
Publicado: (2021)